These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 9067697

  • 1. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
    Guckelberger O, Bechstein WO, Neuhaus R, Luesebrink R, Lemmens HP, Kratschmer B, Jonas S, Neuhaus PL.
    Clin Transplant; 1997 Feb; 11(1):60-5. PubMed ID: 9067697
    [Abstract] [Full Text] [Related]

  • 2. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 4. Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
    Guckelberger O, Langrehr JM, Bechstein WO, Neuhaus R, Luesebrink R, Lemmens HP, Kratschmer B, Jonas S, Knoop M, Neuhaus P.
    Transplant Proc; 1996 Dec; 28(6):3173-4. PubMed ID: 8962230
    [No Abstract] [Full Text] [Related]

  • 5. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM.
    Clin Transplant; 2006 Dec; 20(2):211-20. PubMed ID: 16640529
    [Abstract] [Full Text] [Related]

  • 6. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
    Arora-Gupta N, Davies P, McKiernan P, Kelly DA.
    Pediatr Transplant; 2004 Apr; 8(2):145-50. PubMed ID: 15049794
    [Abstract] [Full Text] [Related]

  • 7. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 9. Renal function in pediatric liver transplantation: a long-term follow-up study.
    Harambat J, Ranchin B, Dubourg L, Liutkus A, Hadj-Haïssa A, Rivet C, Boillot O, Lachaux A, Cochat P.
    Transplantation; 2008 Oct 27; 86(8):1028-34. PubMed ID: 18946339
    [Abstract] [Full Text] [Related]

  • 10. Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation.
    Bianchi G, Nicolino F, Passerini G, Grazi GL, Zappoli P, Graziani R, Berzigotti A, Chianese R, Mantovani V, Pinna AD, Zoli M.
    Liver Transpl; 2006 Jan 27; 12(1):105-11. PubMed ID: 16382457
    [Abstract] [Full Text] [Related]

  • 11. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006 Jan 27; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation.
    Fernández-Miranda C, Sanz M, dela Calle A, Loinaz C, Gómez R, Jiménez C, García I, Gómez de la Cámara A, Moreno E.
    Transpl Int; 2002 Nov 27; 15(11):556-62. PubMed ID: 12461660
    [Abstract] [Full Text] [Related]

  • 13. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
    Chueh SC, Kahan BD.
    Transplantation; 2003 Jul 27; 76(2):375-82. PubMed ID: 12883196
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [Abstract] [Full Text] [Related]

  • 15. Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
    Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delriviere LD, Byrne CD, Alexander GJ.
    Transplantation; 2004 Jan 15; 77(1):93-9. PubMed ID: 14724441
    [Abstract] [Full Text] [Related]

  • 16. Non-lymphoid cancer after liver transplantation.
    Frezza EE, Fung JJ, van Thiel DH.
    Hepatogastroenterology; 1997 Jan 15; 44(16):1172-81. PubMed ID: 9261620
    [Abstract] [Full Text] [Related]

  • 17. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr 15; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 18. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage.
    Shalev A, Nir A, Granot E.
    Pediatr Transplant; 2005 Dec 15; 9(6):718-22. PubMed ID: 16269041
    [Abstract] [Full Text] [Related]

  • 19. Renal function outcome in pediatric liver transplant recipients.
    Mention K, Lahoche-Manucci A, Bonnevalle M, Pruvot FR, Declerck N, Foulard M, Gottrand F.
    Pediatr Transplant; 2005 Apr 15; 9(2):201-7. PubMed ID: 15787794
    [Abstract] [Full Text] [Related]

  • 20. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec 15; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.